GYNECOLOGIC CANCER
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.Read more....

Join our subscribers list to get the latest news, updates and special offers directly in your inbox